Patents by Inventor Christopher LAYTON

Christopher LAYTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED ADENO-ASSOCIATED VIRUS CAPSID PROTEINS AND METHODS THEREOF
    Publication number: 20260001917
    Abstract: The present invention relates to modified recombinant adeno-associated virus (AAV) capsid proteins and AAV particles thereof. In one aspect, the modified recombinant AAV particles provide for increased transduction of retinal cells when compared to the effect of a recombinant AAV particle that does not comprise the modification. The present invention also relates to nucleic acids encoding the modified AAV capsid proteins and AAV particles thereof.
    Type: Application
    Filed: May 31, 2023
    Publication date: January 1, 2026
    Inventors: Christopher LAYTON, Sergei KOZLOV, Jason STEEL
  • EXPRESSION VECTOR AND METHOD
    Publication number: 20210207166
    Abstract: The present disclosure relates to regulatable expression vectors for systematically controlling and silencing expression of a therapeutic molecule and uses thereof, e.g. treating ocular disorders such as choroidal neovascularisation.
    Type: Application
    Filed: January 23, 2019
    Publication date: July 8, 2021
    Inventors: Christopher LAYTON, Jason STEEL